sciencedaily.com / .sciencedaily-com-health

Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug recognizes a unique fold in the RNA and triggers the cell to destroy it. Tests showed that removing this RNA slows cancer ...

Scientists have discovered strange microscopic structures in the blood of people with Long COVID--clusters of tiny microclots tangled together with sticky immune webs known as neutrophil extracellular traps, or NETs. These combined structures show up ...

Colchicine, a cheap and widely used gout drug, may help prevent heart attacks and strokes in people with cardiovascular disease. Trials involving nearly 23,000 patients show meaningful reductions in risk with low doses. Side effects were mostly mild ...

Scientists have uncovered a new environmental culprit behind liver disease: tetrachloroethylene (PCE), a chemical used in dry cleaning and household products. The study found that people with PCE exposure were three times more likely to develop ...

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, semaglutide (Ozempic) and tirzepatide (Mounjaro), not only promote weight loss but also significantly reduce the risk of heart ...

Scientists in Seoul have uncovered 15 gut bacterial species linked to coronary artery disease, showing that microbes can influence heart health far beyond digestion. Their findings reveal how shifts in gut microbial function -- including inflammation ...

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study. Patients on the medications had less than half the mortality rate of non-users. Researchers suspect the drugs' anti ...

Researchers scanning soccer fans' brains found that wins trigger bursts of reward activity while losses dampen control signals. The results show how loyalty and rivalry can override logic, turning competition into an emotional storm. The same brain . ...

Texas A&M scientists have unlocked new potential for astatine-211, a rare and short-lived element, as a highly precise cancer-fighting isotope. Its alpha emissions destroy tumor cells while sparing healthy tissue, making it ideal for targeted therapy ...

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional short-term treatments. The therapy may replace bladder . ...